City National Bank’s Novartis NVS Stock Holding History

City National Bank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.64M	Buy	32,050 +3,336	+12%	+$297K	0.02%	325
2015 Q2	$2.53M	Buy	28,714 +409	+1%	+$37.5K	0.02%	353
2015 Q1	$2.5M	Buy	28,305 +1,745	+7%	+$155K	0.02%	354
2014 Q4	$2.21M	Sell	26,560 -1,481	-5%	-$123K	0.02%	367
2014 Q3	$2.37M	Sell	28,041 -8,927	-24%	-$722K	0.02%	358
2014 Q2	$3M	Buy	36,968 +15,238	+70%	+$1.2M	0.03%	331
2014 Q1	$1.66M	Sell	21,730 -1,785	-8%	-$130K	0.02%	330
2013 Q4	$1.69M	Sell	23,515 -597	-2%	-$41.5K	0.03%	331
2013 Q3	$1.66M	Sell	24,112 -13,677	-36%	-$905K	0.03%	317
2013 Q2	$2.39M	Buy	+37,789	New	+$2.46M	0.04%	287

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

City National Bank's NVS Position: Q3 2015 in Review

City National Bank increased its Novartis (NVS) stake by 12% in Q3 2015, buying an estimated $297K and bringing the position to 32,050 shares worth $2.64M. The position accounts for 0.02% of the portfolio, ranked #325.

City National Bank first reported a position in NVS in Q2 2013 and has held it in 10 quarters since. The position peaked at $3M in Q2 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

City National Bank held 32,050 shares of Novartis worth $2.64M as of Q3 2015.
City National Bank bought 3,336 Novartis shares in Q3 2015, an estimated $297K.
Novartis made up 0.02% of City National Bank's portfolio in Q3 2015, its #325 holding.
City National Bank first reported a position in Novartis in Q2 2013 and has held it in 10 quarters since.
City National Bank's Novartis position peaked at $3M in Q2 2014.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.